Brokerages Set Progyny, Inc. (NASDAQ:PGNY) Target Price at $25.00

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) has earned an average recommendation of "Hold" from the thirteen brokerages that are covering the firm, MarketBeat reports. Nine analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $25.00.

PGNY has been the topic of several analyst reports. Cantor Fitzgerald reiterated an "overweight" rating and set a $25.00 target price on shares of Progyny in a research report on Tuesday, October 1st. Truist Financial reiterated a "hold" rating and issued a $19.00 price target (down from $26.00) on shares of Progyny in a research report on Wednesday, November 13th. Canaccord Genuity Group decreased their price objective on shares of Progyny from $18.00 to $17.00 and set a "hold" rating on the stock in a research report on Wednesday, November 13th. JMP Securities lowered shares of Progyny from an "outperform" rating to a "market perform" rating in a research report on Thursday, September 19th. Finally, Jefferies Financial Group lowered their target price on Progyny from $31.00 to $24.00 and set a "buy" rating for the company in a research report on Thursday, September 19th.

Progyny Stock Down 0.6 %

NASDAQ:PGNY traded down $0.10 on Tuesday, hitting $15.74. The stock had a trading volume of 1,645,784 shares, compared to its average volume of 1,401,484. Progyny has a 52-week low of $13.39 and a 52-week high of $42.08. The stock has a market cap of $1.34 billion, a price-to-earnings ratio of 27.14, a price-to-earnings-growth ratio of 1.66 and a beta of 1.35. The business's 50-day simple moving average is $15.60 and its two-hundred day simple moving average is $21.55.

Progyny (NASDAQ:PGNY - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.26). The business had revenue of $286.63 million for the quarter, compared to analysts' expectations of $296.85 million. Progyny had a net margin of 5.03% and a return on equity of 11.36%. The firm's quarterly revenue was up 2.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.16 earnings per share. As a group, equities research analysts anticipate that Progyny will post 0.59 EPS for the current year.

Institutional Trading of Progyny

Several institutional investors and hedge funds have recently modified their holdings of the stock. RiverPark Advisors LLC raised its holdings in shares of Progyny by 9.6% in the 2nd quarter. RiverPark Advisors LLC now owns 5,408 shares of the company's stock valued at $155,000 after purchasing an additional 474 shares in the last quarter. Arizona State Retirement System lifted its holdings in Progyny by 2.6% during the second quarter. Arizona State Retirement System now owns 24,313 shares of the company's stock worth $696,000 after buying an additional 609 shares during the period. State of New Jersey Common Pension Fund D boosted its position in Progyny by 1.1% during the 2nd quarter. State of New Jersey Common Pension Fund D now owns 70,717 shares of the company's stock valued at $2,023,000 after acquiring an additional 787 shares in the last quarter. Quarry LP increased its holdings in shares of Progyny by 1,900.0% in the 2nd quarter. Quarry LP now owns 880 shares of the company's stock valued at $25,000 after acquiring an additional 836 shares during the period. Finally, Creative Planning raised its position in shares of Progyny by 13.8% in the 2nd quarter. Creative Planning now owns 10,564 shares of the company's stock worth $302,000 after acquiring an additional 1,283 shares in the last quarter. Institutional investors own 94.93% of the company's stock.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.